Buteyko breathing for seniors with chronic obstructive Eustachian tube dysfunction
Efficacy of Buteyko Breathing in Seniors With Chronic Eustachian Tube Dysfunction
NA · Cairo University · NCT07193485
This trial will try adding daily Buteyko breathing exercises to usual care to see if it helps seniors with chronic Eustachian tube dysfunction.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 65 Years to 75 Years |
| Sex | All |
| Sponsor | Cairo University (other) |
| Locations | 1 site (Dokki, Giza Governorate) |
| Trial ID | NCT07193485 on ClinicalTrials.gov |
What this trial studies
Forty seniors with unilateral, chronic obstructive Eustachian tube dysfunction lasting more than three months will be randomized into two groups of 20. Both groups will receive usual care consisting of budesonide nasal spray (64 micrograms once daily) plus a tablet twice daily containing pseudoephedrine 20 mg and loratadine 5 mg for two weeks. One group will additionally perform 30-minute Buteyko breathing sessions twice daily for 14 weeks. Key exclusions include obesity and significant cardiac or respiratory disease, and the trial is conducted at Cairo University in Dokki, Giza.
Who should consider this trial
Good fit: Ideal candidates are seniors with unilateral chronic obstructive Eustachian tube dysfunction persisting longer than three months who do not have obesity or major cardiac or respiratory disease.
Not a fit: Patients with obesity, significant cardiac or respiratory conditions, bilateral or non-obstructive Eustachian dysfunction, or other contraindications are unlikely to benefit or may be excluded.
Why it matters
Potential benefit: If successful, adding Buteyko breathing could reduce ear pressure symptoms and improve Eustachian tube function without more medications.
How similar studies have performed: Buteyko breathing has some use in other airway conditions, but its application to Eustachian tube dysfunction is novel with limited prior evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Eustachian Tube Dysfunction (chronic obstructive form) * unilateral ear affetion * senior patients * chronci affection more than 3 months Exclusion Criteria: * obesity * cardiac probelms repsiratory problems
Where this trial is running
Dokki, Giza Governorate
- Cairo University — Dokki, Giza Governorate, Egypt (RECRUITING)
Study contacts
- Principal investigator: Ali MA Ismail, lecturer — Cairo University
- Study coordinator: Ali MA Ismail, lecturer
- Email: ali.mohamed@pt.cu.edu.eg
- Phone: 01005154209
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Eustachian Tube Dysfunction